Profile

New User

New to Graphy Publications? Create an account to get started today.

Registered Users

Have an account? Sign in now.

How to Cite | Author Information | Publication History | Funding Information
International Journal of Gastroenterology Disorders & Therapy Volume 3 (2016), Article ID 3:IJGDT-120, 2 pages
https://doi.org/10.15344/2393-8498/2016/120
Expert Opinion
Assessment of Cancer Screenings and Impact of Computer Simulation

Hiroshi Nishida1,2*, Akiko Harada3, Takahiro Matsusmoto3, Tomoko Tani3, Yoshihide Tatsumi1, Etsuko Nagai2 and Shuko Mayumi2

1Health Care Center, Panasonic Health Insurance Organization, Osaka, Japan
2Department of Preventive Medicine, Matsushita Memorial Hospital, Panasonic Health Insurance Organization, Osaka, Japan
3Department of Gastroenterology, Matsushita Memorial Hospital, Panasonic Health Insurance Organization, Osaka, Japan
Dr. Hiroshi Nishida, Health Care Center, Panasonic Health Insurance Organization, 5-55 Sotojima-cho, Moriguchi, Osaka 570-8540, Japan; E-mail: hnishida-ind@umin.ac.jp
30 November 2015; 03 January 2016; 05 January 2016
Nishida H, Harada, Matsusmoto T, Tani T, Tatsumi Y, et al. (2016) Assessment of Cancer Screenings and Impact of Computer Simulation. Int J Gastroenterol Disord Ther 3: 120. doi: https://doi.org/10.15344/2393-8498/2016/120
This paper was supported by the Health Labour Sciences Grant (H27-006).
© 2016 Nishida et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

References

  1. Gupta SK (2011) Intention-to-treat concept: A review. Perspect Clin Res 2: 109-112. View
  2. Montori VM, Guyatt GH (2001) Intention-to-treat principle. CMAJ 165: 1339-1341. View
  3. Harbour R, Miller J (2001) A new system for grading recommendations in evidence based guidelines. BMJ 323: 334-336. View
  4. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, et al. (1993) Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328: 1365- 1371. View
  5. Mandel JS, Church TR, Ederer F, Bond JH (1999) Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 91: 434-437. View
  6. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, et al. (2000) The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 343: 1603-1607. View
  7. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, et al. (1996) Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348: 1472-1477. View
  8. Scholefield JH, Moss S, Sufi F, Mangham CM, Hardcastle JD (2002) Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial. Gut 50: 840-844. View
  9. Kronborg O, Jørgensen OD, Fenger C, Rasmussen M (2004) Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scand J Gastroenterol 39: 846-851. View
  10. Hewitson P, Glasziou P, Irwig L, Towler B, Watson E (2011) Screening for colorectal cancer using the faecal occult blood test, Hemoccult. The Cochrane collaboration. John Wiley & Sons, Ltd. Hoboken, NJ.USA, pp.1- 38.
  11. Bondyopadhyay PK (1998) Moore’s law governs the silicon revolution. IEEE 86: 78-81. View
  12. Kurzweil R (2004) The law of accelerating return. Teucher C. eds. Alan Turing: Life and legacy of a great thinker. Springer, Berlin, Germany, pp.381-416.
  13. Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, et al. (2010) Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multi-centre randomized controlled trial. Lancet 375:1624-1633. View
  14. Segnan N, Armaroli P, Bonelli L, Risio M, Sciallero S, et al. (2011) Onceonly sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial —SCORE. J Natl Cancer Inst 103: 1310-1322. View
  15. Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, et al. (2012) Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 366: 2345-2357. View
  16. Quintero E, Castells A, Bujanda L, Cubiella J, Salas D, et al. (2012) Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med 366: 697-706. View
  17. Hultcrantz R (2014) Colonoscopy and FIT as colorectal cancer screening test in the average risk population. View
  18. Department of veterans affairs (2010) Colonoscopy versus fecal immunochemical test in reducing mortality from colorectal cancer (COMFIRM). View
  19. Castells A (2009) Colorectal cancer screening in average-risk population: immunochemical fecal blood testing versus colonoscopy. View
  20. Hoff G (2009) Telemark polyp study, a trial on colonoscopy screening (TPS). View
  21. Norwegian department of health and social affairs (2009) The Northrn- European initiative on colorectal cancer (NordICC). View
  22. Shin-ei K (2009) Randomized Controlled trial to evaluate the effectiveness of total colonoscopy in colorectal cancer screening. View
  23. Kahi CJ, Imperiale TF, Juliar BE, Rex DK (2009) Effect of screening colonoscopy on colorectal cancer incidence and mortality. Clin Gastroenterol Hepatol 7: 770-775. View
  24. Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, et al. (2009) Association of colonoscopy and death from colorectal cancer. Ann Intern Med 150: 1-8. View
  25. Singh H, Nugent Z, Demers AA, Kliewer EV, Mahmud SM, et al. (2010) The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer. Gastroenterology 139: 1128-1137. View
  26. Nishihara R, Wu K, Lochhead P, Morikawa T, Liao X, et al. (2013) Longterm colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med 369: 1095-1105. View
  27. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, et al. (2008) Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med 149: 659-669. View
  28. Loeve F, Boer R, van Oortmarssen GJ, van Ballegooijen M, Habbema JD (1999) The MISCAN-COLON simulation model for the evaluation of colorectal cancer screenin. Comput Biomed Res 32: 13-33. View
  29. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, et al. (1993) Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 329: 1977-1981. View
  30. Zauber AG, Winawer SJ, O'Brien MJ, Lansdorp-Vogelaar I, van Ballegooijen M, et al. (2012) Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 366: 687-696. View
Best viewed in Mozilla Firefox, Google Chrome, Safari, Above IE 9.0 version
Privacy Policy | Copyright & Permissions
Copyright © 2013-2024 Graphy Publications, All Rights Reserved.